chemotherapy-induced neutropenia
Oncology · 2010–2020
5decisions
3medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| pegfilgrastim Treatment of chemotherapy-induced neutropenia in cancer patients receiving chemotherapy with the intention of achieving a cure or substantial remission, who… | Mar 2020 | Recommended | none received |
| pegfilgrastim Chemotherapy-induced neutropenia in cancer patients receiving chemotherapy with the intention of achieving cure or substantial remission, for those at greater… | Nov 2019 | Recommended | none received |
| pegfilgrastim Treatment of chemotherapy-induced neutropenia in patients receiving chemotherapy for various malignancies including acute myeloid leukaemia, breast cancer,… | Jul 2018 | Noted | none received |
| lipegfilgrastim Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy. | Mar 2016 | Noted | input received |
| filgrastim Similar biological medicinal product (biosimilar) to filgrastim (Neupogen) for reduction of neutropenia duration and clinical sequelae in patients undergoing… | Nov 2010 | Recommended with restriction | no section in document |
What the PBS pays
$99M in government benefit over 2024–25, across 138,850 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| lipegfilgrastim | $89.6M |
| filgrastim | $4.7M |
| pegfilgrastim | $4.3M |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 4 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.